Earnings Call · Q1 FY2024·2024-05-02

Ascendis Pharma A/S ASND

Timothy Lee — Senior Director, Investor Relations

Jan Mikkelsen — President and Chief Executive Officer

Now let me give an update on each of our programs. When we launched SKYTROFA in the U.S. about 2 years ago, we had 2 goals

This is our integrated approach to address achondroplasia with multiple trials that are all building towards one goal

Scott Smith — Executive Vice President and Chief Financial Officer

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ASND calls or request research access.

More ASND calls Browse calls Request research access